ATE468135T1 - Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie- vakzine auf die schleimhäute - Google Patents
Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie- vakzine auf die schleimhäuteInfo
- Publication number
- ATE468135T1 ATE468135T1 AT05800771T AT05800771T ATE468135T1 AT E468135 T1 ATE468135 T1 AT E468135T1 AT 05800771 T AT05800771 T AT 05800771T AT 05800771 T AT05800771 T AT 05800771T AT E468135 T1 ATE468135 T1 AT E468135T1
- Authority
- AT
- Austria
- Prior art keywords
- allergen
- preventive treatment
- allergy
- subject
- allergies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62645404P | 2004-11-10 | 2004-11-10 | |
DKPA200401730 | 2004-11-10 | ||
US68691405P | 2005-06-03 | 2005-06-03 | |
PCT/DK2005/000716 WO2006050729A2 (en) | 2004-11-10 | 2005-11-08 | Method of preventive treatment of allergy by mucosal administration of an allergy vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE468135T1 true ATE468135T1 (de) | 2010-06-15 |
Family
ID=35840082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05800771T ATE468135T1 (de) | 2004-11-10 | 2005-11-08 | Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie- vakzine auf die schleimhäute |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060121064A1 (de) |
EP (1) | EP1812059B1 (de) |
JP (1) | JP5628473B2 (de) |
AT (1) | ATE468135T1 (de) |
AU (1) | AU2005304107B2 (de) |
CA (1) | CA2586283A1 (de) |
DE (1) | DE602005021388D1 (de) |
HK (1) | HK1108568A1 (de) |
MX (1) | MX2007005523A (de) |
PL (1) | PL1812059T3 (de) |
WO (1) | WO2006050729A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006310881B2 (en) * | 2005-11-04 | 2012-07-19 | Alk-Abello A/S | Use of a liquid allergy vaccine formulation for oromucosal administration |
WO2009087175A2 (en) * | 2008-01-08 | 2009-07-16 | Alk-Abelló A/S | Allergy vaccine composition for mucosal administration |
DE202008006598U1 (de) * | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung |
US10080810B2 (en) | 2008-07-17 | 2018-09-25 | John Shea | Method for testing and treating delayed food allergies |
WO2010009417A1 (en) * | 2008-07-17 | 2010-01-21 | John Shea | Method for testing and treating delayed food allergies |
CN103025303A (zh) * | 2010-04-30 | 2013-04-03 | 艾洛维特有限责任公司(Allovate,Llc) | 经由口腔粘膜变应性脱敏的方法、制品和试剂盒 |
EP3305319A1 (de) | 2010-04-30 | 2018-04-11 | Allovate, LLC | Verfahren und artikel zur verhinderung oder verringerung des risikos der entwicklung eines hyperallegenen immunsystems |
ES2549591T3 (es) * | 2010-10-15 | 2015-10-29 | Alk-Abelló A/S | Supresión de una respuesta inmunitaria de hipersensibilidad con un antígeno no relacionado derivado de material fuente de alérgenos |
US20120100163A1 (en) * | 2010-10-15 | 2012-04-26 | Alk-Abello A/S | Suppression of a type 1 hypersensitivity immune response with an unrelated antigen |
FI20115375A0 (fi) | 2011-04-18 | 2011-04-18 | Teknologian Tutkimuskeskus Vtt Oy | Uudet hypoallergeenit |
FI20115374A0 (fi) | 2011-04-18 | 2011-04-18 | Teknologian Tutkimuskeskus Vtt Oy | Uudet hypoallergeenit |
EP2952200A1 (de) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergen zur vorbeugenden Behandlung von Allergien |
KR101858840B1 (ko) * | 2016-01-15 | 2018-05-16 | 단국대학교 천안캠퍼스 산학협력단 | 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제 |
FI128016B (en) | 2018-01-04 | 2019-07-31 | Desentum Oy | Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy |
CN110531059A (zh) * | 2019-09-27 | 2019-12-03 | 中国海洋大学 | 一种食物过敏原动态消化模型和体外模拟评价方法 |
CN115735854A (zh) * | 2022-11-15 | 2023-03-07 | 中国农业大学 | 一种榛子食物过敏的动物模型构建方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63159324A (ja) * | 1986-12-22 | 1988-07-02 | Lion Corp | スギ花粉症用経口ワクチン |
AUPM307793A0 (en) * | 1993-12-22 | 1994-01-20 | Holt, Patrick G Professor | Prophylaxis of allergic disease |
JPH09315998A (ja) * | 1996-05-30 | 1997-12-09 | Japan Tobacco Inc | スギ花粉症の予防および/または治療剤 |
CN1338947B (zh) * | 1999-02-05 | 2012-11-14 | 爱尔开-阿贝优公司 | 粘膜递送系统 |
US20030175312A1 (en) * | 2000-11-16 | 2003-09-18 | Alk-Abello A/S | Novel mutant allergens |
WO2003096869A2 (en) * | 2002-05-16 | 2003-11-27 | Alk Abelló A/S | Recombinant bet. v. 1. allergen mutants, methods and process thereof |
WO2004047793A1 (en) * | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
-
2005
- 2005-11-08 DE DE602005021388T patent/DE602005021388D1/de active Active
- 2005-11-08 AT AT05800771T patent/ATE468135T1/de active
- 2005-11-08 MX MX2007005523A patent/MX2007005523A/es active IP Right Grant
- 2005-11-08 WO PCT/DK2005/000716 patent/WO2006050729A2/en active Application Filing
- 2005-11-08 CA CA002586283A patent/CA2586283A1/en not_active Abandoned
- 2005-11-08 AU AU2005304107A patent/AU2005304107B2/en not_active Ceased
- 2005-11-08 PL PL05800771T patent/PL1812059T3/pl unknown
- 2005-11-08 EP EP05800771A patent/EP1812059B1/de not_active Revoked
- 2005-11-08 JP JP2007540494A patent/JP5628473B2/ja not_active Expired - Fee Related
- 2005-11-09 US US11/269,681 patent/US20060121064A1/en not_active Abandoned
-
2007
- 2007-12-19 HK HK07113823.9A patent/HK1108568A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP5628473B2 (ja) | 2014-11-19 |
AU2005304107A1 (en) | 2006-05-18 |
CA2586283A1 (en) | 2006-05-18 |
AU2005304107B2 (en) | 2011-06-02 |
MX2007005523A (es) | 2007-07-05 |
EP1812059B1 (de) | 2010-05-19 |
WO2006050729A3 (en) | 2006-08-24 |
EP1812059A2 (de) | 2007-08-01 |
HK1108568A1 (en) | 2008-05-09 |
DE602005021388D1 (de) | 2010-07-01 |
WO2006050729A2 (en) | 2006-05-18 |
JP2008519776A (ja) | 2008-06-12 |
PL1812059T3 (pl) | 2010-10-29 |
US20060121064A1 (en) | 2006-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE468135T1 (de) | Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie- vakzine auf die schleimhäute | |
DE502005010615D1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
ATE432693T1 (de) | Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden | |
ATE519488T1 (de) | Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten | |
DE602004028841D1 (de) | Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c | |
ATE395052T1 (de) | Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes | |
DE602006010442D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
HK1118282A1 (en) | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase | |
TW200740801A (en) | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase | |
RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
SE0301882D0 (sv) | New use I | |
JP2008519776A5 (de) | ||
DE602006020775D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von manie und bipolaren störungen | |
ATE511835T1 (de) | Biophosphonate zur behandlung von endometriose | |
ATE407690T1 (de) | Topische pharmazeutische zusammensetzungen enthaltend aktive natürliche bestandteile zur verhütung und behandlung von mucosalen entzündungprozessen | |
DE112004000961D2 (de) | Verwendung von Wirksubstanzen zur Vorbeugung oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen | |
RU2008130825A (ru) | Применение экстракта бузины | |
ATE499933T1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
ATE480232T1 (de) | Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden | |
ATE503476T1 (de) | Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind | |
DE60325275D1 (de) | Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen | |
SE0301884D0 (sv) | New use III | |
SE0301885D0 (sv) | New use IV | |
TW200613032A (en) | Uses for augmenting bone | |
ATE505193T1 (de) | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1812059 Country of ref document: EP |